INCOME TAXES - Summary of Source Differences Between Income Taxes at the Federal Statutory Rate and the Provision for Income Taxes (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Tax Disclosure [Abstract] | ||||||
| Tax benefit at the statutory rate | $ (7,249,161) | $ (4,346,294) | ||||
| Increase (decrease) in taxes resulting from: | ||||||
| State taxes | (1,583,965) | (400,290) | ||||
| Stock-based compensation | 34,599 | 82,430 | ||||
| Research and development tax credits | (100,311) | (418,321) | ||||
| Loss on debt extinguishment | 4,305,904 | |||||
| Deferred tax true-ups and other | (1,037,064) | (167,497) | ||||
| Change in valuation allowance | 5,629,998 | 5,249,972 | ||||
| Total income tax expense (benefit) | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |
| X | ||||||||||
- Definition Income tax reconciliation deferred tax true-ups and other. No definition available.
|
| X | ||||||||||
- Definition Income tax reconciliation loss on debt extinguishment. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|